PINK:NUNZ

Nunzia Pharmaceutical Stock Insider Trading

> Drug Manufacturers - Specialty & Generic

Buy NUNZ

*Your capital is at risk

$0.0001

+0 (+0%)

At Close: Jun 02, 2026

Nunzia Pharmaceutical Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 122.97M and sold 109.17M NUNZ shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	0
● Buy	122.97M shares
● Sell	109.17M shares
68% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Oct 30, 2006 Buy	Common Stock P-Purchase	Henry G David	Director	25 000 Value: $500
Oct 30, 2006 Buy	Common Stock P-Purchase	Henry G David	Director	25 000 Value: $500
Oct 18, 2006 Buy	Common Stock P-Purchase	Henry G David	Director	100 000 Value: $2K
Oct 18, 2006 Buy	Common Stock P-Purchase	Henry G David	Director	100 000 Value: $2K
Jun 14, 2006 Buy	Common Stock P-Purchase	Henry G David	Director	10 000 Value: $180
Jun 14, 2006 Buy	Common Stock P-Purchase	Henry G David	Director	10 000 Value: $180
May 03, 2006 Buy	Common Stock P-Purchase	Henry G David	Director	3 913 Value: $157
May 03, 2006 Buy	Common Stock P-Purchase	Henry G David	Director	3 913 Value: $157
May 02, 2006 Buy	Common Stock P-Purchase	Henry G David	Director	55 000 Value: $23.3K
May 02, 2006 Buy	Common Stock P-Purchase	Henry G David	Director	55 000 Value: $23.3K
Apr 28, 2006 Buy	Common Stock P-Purchase	Henry G David	Director	110 000 Value: $5K
Apr 28, 2006 Buy	Common Stock P-Purchase	Henry G David	Director	110 000 Value: $5K
Apr 14, 2006 Buy	Class A Common Shares A-Award	Hitz Kingman L CFO	C-Suite Officer	500 000 Value: $10.0K
Apr 14, 2006 Buy	Class A Common Shares A-Award	Hitz Kingman L CFO	C-Suite Officer	500 000 Value: $10.0K
Jan 30, 2006 Sell	Common Stock S-Sale	Henry G David	Director	5 386 667 Value: $0
Jan 30, 2006 Sell	Common Stock S-Sale	Henry G David	Director	5 386 667 Value: $0
Dec 29, 2005 Buy	Common Stock P-Purchase	Henry G David	Director	34 698 Value: $1K
Dec 29, 2005 Buy	Common Stock P-Purchase	Henry G David	Director	34 698 Value: $1K
Dec 29, 2005 Buy	Common Stock P-Purchase	Henry G David	Director	34 698 Value: $1K
Dec 29, 2005 Buy	Common Stock A-Award	Kron Roger Alan Chief Operating Officer	C-Suite Officer	500 000 Value: $10.0K
Dec 29, 2005 Buy	Common Stock P-Purchase	Henry G David	Director	34 698 Value: $1K
Dec 29, 2005 Buy	Common Stock A-Award	Kron Roger Alan Chief Operating Officer	C-Suite Officer	500 000 Value: $10.0K
Dec 16, 2005 Buy	Common Stock A-Award	Henry G David	Director	2 500 000 Value: $50.0K
Dec 16, 2005 Sell	Common Stock G-Gift	Henry G David	Director	1 250 000 Value: $0
Dec 16, 2005 Sell	Common Stock G-Gift	Henry G David	Director	1 250 000 Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT NUNZIA PHARMACEUTICAL CORPORATION

Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical ...

Read Full Profile Here